Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Dexcom (DXCM) Income from Continuing Operations (2016 - 2025)

Dexcom (DXCM) has disclosed Income from Continuing Operations for 16 consecutive years, with 267300000.0 as the latest value for Q4 2025.

  • On a quarterly basis, Income from Continuing Operations rose 76.2% to 267300000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was 836300000.0, a 45.14% increase, with the full-year FY2025 number at 836300000.0, up 45.14% from a year prior.
  • Income from Continuing Operations was 267300000.0 for Q4 2025 at Dexcom, down from 283800000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 283800000.0 in Q3 2025 to a low of 48600000.0 in Q1 2023.
  • A 5-year average of 128940000.0 and a median of 110650000.0 in 2023 define the central range for Income from Continuing Operations.
  • Peak YoY movement for Income from Continuing Operations: tumbled 86.26% in 2021, then surged 201.23% in 2024.
  • Dexcom's Income from Continuing Operations stood at 56500000.0 in 2021, then surged by 62.48% to 91800000.0 in 2022, then soared by 179.19% to 256300000.0 in 2023, then crashed by 40.81% to 151700000.0 in 2024, then surged by 76.2% to 267300000.0 in 2025.
  • Per Business Quant, the three most recent readings for DXCM's Income from Continuing Operations are 267300000.0 (Q4 2025), 283800000.0 (Q3 2025), and 179800000.0 (Q2 2025).